Genco Lab submitted claims for medically unnecessary urine drug tests for Medicare, Medicaid beneficiaries living in sober houses: Feds.

BRSNFORD, CT — Branford-based Genco Lab and its owners and officers, Paul Conroy, Tricia Conroy and Charles Orefice entered into a civil settlement agreement with the federal and state governments and agreed to pay more than $1.2 million to settle allegations that they submitted false and fraudulent claims to government health care programs for medically unnecessary urine drug tests, according to David X. Sullivan, United States Attorney for the District of Connecticut,.

Paul Conroy is the majority owner, Orefice is a part owner, and Tricia Conroy is the Chief Operating Officer of Genco Lab, a reference laboratory, Sullivan said.

According to Sullivan, its alleged that Genco and its owners and officers "committed fraud in two ways."

"First, they submitted claims for medically unnecessary urine drug tests for Medicare and Medicaid beneficiaries residing in sober homes solely for the purposes of 'residential monitoring, which was explicitly prohibited and secondly, they submitted claims for medically unnecessary duplicative urine drug testing," Sullivan said.

According to the federal prosecutor, there are several types of urine drug testing.

"A screening test, also called a 'presumptive' test, detects the presence or absence of certain classes of drugs, such as opiates, cocaine, and amphetamines. A screening test does not measure the...

Read Full Story: https://news.google.com/rss/articles/CBMiuAFBVV95cUxPem9nQnhoeGplUFBFX3MyRFJh...